Ports and complications for intraperitoneal chemotherapy delivery
Article first published online: 21 OCT 2011
© 2011 The Author BJOG An International Journal of Obstetrics and Gynaecology © 2011 RCOG
BJOG: An International Journal of Obstetrics & Gynaecology
Special Issue: Gynaecological oncology
Volume 119, Issue 2, pages 150–159, January 2012
How to Cite
Helm, C. (2012), Ports and complications for intraperitoneal chemotherapy delivery. BJOG: An International Journal of Obstetrics & Gynaecology, 119: 150–159. doi: 10.1111/j.1471-0528.2011.03179.x
- Issue published online: 13 DEC 2011
- Article first published online: 21 OCT 2011
- Accepted 7 September 2011. Published Online 21 October 2011.
- Intraperitoneal chemotherapy;
- intraperitoneal catheter;
- ovarian cancer
Please cite this paper as: Helm C. Ports and complications for intraperitoneal chemotherapy delivery. BJOG 2012;119:150–159.
Intraperitoneal access ports are essential to the delivery of chemotherapy agents into the peritoneal cavity of women with ovarian cancer, but their malfunction and adverse effects are frequently responsible for the failure to complete planned therapy. Complications, such as obstruction of the catheter, infection, leakage, rotation, retraction, and pain, together with bowel and vaginal perforation, cause delays in treatment, patient suffering and the expenditure of medical resources. A wide variety of ports have been used, including vascular access devices and intraperitoneal access devices. This paper reviews the development and use of ports for intraperitoneal chemotherapy, their complications and reported methods of prevention.